Tim Kümmerle

3.9k total citations
20 papers, 225 citations indexed

About

Tim Kümmerle is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Tim Kümmerle has authored 20 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Epidemiology and 5 papers in Virology. Recurrent topics in Tim Kümmerle's work include HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV Research and Treatment (4 papers). Tim Kümmerle is often cited by papers focused on HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (6 papers) and HIV Research and Treatment (4 papers). Tim Kümmerle collaborates with scholars based in Germany, United States and Netherlands. Tim Kümmerle's co-authors include Christoph Wyen, Gerd Fätkenheuer, Jürgen K. Rockstroh, Christoph Boesecke, Clara Lehmann, Oliver A. Cornely, Martin Vogel, Jörg Janne Vehreschild, Gaby Knecht and Norma Jung and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Antimicrobial Chemotherapy and Epidemiology and Infection.

In The Last Decade

Tim Kümmerle

20 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Kümmerle Germany 9 144 106 87 36 34 20 225
Οlga Tsachouridou Greece 10 130 0.9× 137 1.3× 14 0.2× 21 0.6× 47 1.4× 47 242
Maria Cristina Uccelli Italy 10 81 0.6× 120 1.1× 36 0.4× 12 0.3× 54 1.6× 16 216
Tanakorn Apornpong Thailand 10 152 1.1× 134 1.3× 40 0.5× 23 0.6× 130 3.8× 40 344
Gaby Knecht Germany 9 108 0.8× 140 1.3× 92 1.1× 9 0.3× 71 2.1× 19 224
Kathrin van Bremen Germany 7 145 1.0× 92 0.9× 73 0.8× 11 0.3× 76 2.2× 17 244
S. Paccagnini Italy 6 352 2.4× 72 0.7× 343 3.9× 16 0.4× 25 0.7× 12 446
José Antonio Mata‐Marín Mexico 9 150 1.0× 121 1.1× 101 1.2× 11 0.3× 78 2.3× 41 273
B Salassa Italy 10 231 1.6× 258 2.4× 72 0.8× 37 1.0× 114 3.4× 17 413
Heather Platt United States 10 415 2.9× 150 1.4× 294 3.4× 10 0.3× 7 0.2× 29 532
Margherita Bracchi United Kingdom 7 98 0.7× 187 1.8× 29 0.3× 8 0.2× 126 3.7× 25 268

Countries citing papers authored by Tim Kümmerle

Since Specialization
Citations

This map shows the geographic impact of Tim Kümmerle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Kümmerle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Kümmerle more than expected).

Fields of papers citing papers by Tim Kümmerle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Kümmerle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Kümmerle. The network helps show where Tim Kümmerle may publish in the future.

Co-authorship network of co-authors of Tim Kümmerle

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Kümmerle. A scholar is included among the top collaborators of Tim Kümmerle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Kümmerle. Tim Kümmerle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monin, Malte B., Tim Kümmerle, Jochen Schneider, et al.. (2022). Switching to a NRTI-free 2 drug regimen (2DR) –a sub-analysis of the 48 weeks DUALIS study on metabolic and renal changes. SHILAP Revista de lepidopterología. 23(1). 15–21. 1 indexed citations
2.
Wolf, Eva, Christoph Boesecke, Hans Heiken, et al.. (2021). Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance. AIDS Research and Therapy. 18(1). 58–58. 3 indexed citations
3.
Paul, Gregor, Jakob J Malin, Isabelle Suárez, et al.. (2020). Predictors of serofast state after treatment for early syphilis in HIV‐infected patients. HIV Medicine. 22(3). 165–171. 4 indexed citations
4.
Spinner, Christoph D., Christoph Boesecke, Christoph Wyen, et al.. (2018). Prevalence of asymptomatic sexually transmitted infections in HIV-positive men who have sex with men in Germany: results of a multicentre cross-sectional study. Infection. 46(3). 341–347. 16 indexed citations
5.
Suárez, Isabelle, Martin Platten, Tim Kümmerle, et al.. (2018). To prescribe, or not to prescribe: decision making in HIV‐1 post‐exposure prophylaxis. HIV Medicine. 19(9). 645–653. 6 indexed citations
6.
Spinner, Christoph D., Tim Kümmerle, Ivanka Krznaric, et al.. (2017). Pharmacokinetics of once-daily dolutegravir and ritonavir-boosted darunavir in HIV patients: the DUALIS study. Journal of Antimicrobial Chemotherapy. 72(9). 2679–2681. 8 indexed citations
7.
Draenert, Rika, Clara Lehmann, Melanie Stecher, et al.. (2016). Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany. Epidemiology and Infection. 145(2). 236–244. 9 indexed citations
8.
Schwarze‐Zander, Carolynne, Tim Kümmerle, Christoph Boesecke, et al.. (2016). How successful is influenza vaccination in HIV infected patients? Results from an influenza A(H1N1)pdm09 vaccine study. HIV & AIDS Review. 15(3). 111–115. 2 indexed citations
9.
Firląg‐Burkacka, Ewa, Caroline Sabin, Tim Kümmerle, et al.. (2015). Clinical and epidemiological characteristics of patients with early syphilis from three academic centres in Poland, Germany and Ireland: initial findings from the POETS study. Sexually Transmitted Infections. 91(6). 389–394. 2 indexed citations
10.
Freyhaus, Henrik ten, Clara Lehmann, Tim Kümmerle, et al.. (2014). Echocardiographic screening for pulmonary arterial hypertension in HIV-positive patients. Infection. 42(4). 737–741. 18 indexed citations
11.
Platten, Martin, Rachel W. Linnemann, Tim Kümmerle, et al.. (2014). Clinical course and quality of care in ART-naïve patients newly presenting in a HIV outpatient clinic. Infection. 42(5). 849–857. 8 indexed citations
12.
Kümmerle, Tim, Jörg Janne Vehreschild, Julia Fischer, et al.. (2013). Causes of death in HIV-infected patients from the Cologne–Bonn cohort. Infection. 42(1). 135–140. 30 indexed citations
13.
Jung, Norma, Tim Kümmerle, Clara Lehmann, et al.. (2012). Liver involvement in HIV-infected patients diagnosed with syphilis. Infection. 40(5). 543–547. 12 indexed citations
14.
Kümmerle, Tim, Gerd Fätkenheuer, & Michael Hallek. (2012). Tollwut-Impfung: wann und wie?. DMW - Deutsche Medizinische Wochenschrift. 137(15). 789–792. 1 indexed citations
15.
Kümmerle, Tim, Sven D. Koch, Carolynne Schwarze‐Zander, et al.. (2011). Acceptance and tolerability of an adjuvanted nH1N1 vaccine in HIV-infected patients in the cologne-bonn cohort. European journal of medical research. 16(7). 289–289. 3 indexed citations
16.
Vogel, Martin, Bernd Kupfer, Hans‐Jürgen Stellbrink, et al.. (2010). Phylogenetic analysis of acute hepatitis C virus genotype 4 infections among human immunodeficiency virus-positive men who have sex with men in Germany. Liver International. 30(8). 1169–1172. 29 indexed citations
17.
Kümmerle, Tim, Clara Lehmann, Pia Hartmann, Christoph Wyen, & Gerd Fätkenheuer. (2009). Vicriviroc: a CCR5 antagonist for treatment-experienced patients with HIV-1 infection. Expert Opinion on Investigational Drugs. 18(11). 1773–1785. 6 indexed citations
18.
Vehreschild, Jörg Janne, Tim Kümmerle, Meinolf Karthaus, & Oliver A. Cornely. (2007). Anidulafungin – state of affairs from a clinical perspective. Mycoses. 50(s1). 38–43. 11 indexed citations
19.
Vogel, Martin, Jacob Nattermann, Axel Baumgarten, et al.. (2006). Pegylated Interferon-α for the Treatment of Sexually Transmitted Acute Hepatitis C in HIV-Infected Individuals. Antiviral Therapy. 11(8). 1097–1102. 52 indexed citations
20.
Hoffmann, G. M., et al.. (1999). [Value of p53, urokinase plasminogen activator, PAI-1 and Ki-67 in vulvar carcinoma].. PubMed. 121(10). 473–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Οlga Tsachouridou Breakdown of academic impact, for papers by Maria Cristina Uccelli Breakdown of academic impact, for papers by Tanakorn Apornpong Breakdown of academic impact, for papers by Gaby Knecht Breakdown of academic impact, for papers by Kathrin van Bremen Breakdown of academic impact, for papers by S. Paccagnini Breakdown of academic impact, for papers by José Antonio Mata‐Marín Breakdown of academic impact, for papers by B Salassa Breakdown of academic impact, for papers by Heather Platt Breakdown of academic impact, for papers by Margherita Bracchi
Rankless by CCL
2026